We are live on
!
Find out more
AAP
Aristotle Atlantic Partners Portfolio holdings
AUM
$2.14B
1-Year Est. Return
37.01%
This Fund
S&P 500
This Quarter
Est. Return
+5.51%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
–
AUM
$3.18B
AUM Growth
-$35.8M
(-1.1%)
Cap. Flow
-$157M
Cap. Flow
% of AUM
-4.93%
Top 10 Holdings %
Top 10 Hldgs %
52.66%
Holding
97
New
2
Increased
6
Reduced
58
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$12.9M |
| 2 |
Bank of America
BAC
|
+$9.62M |
| 3 |
Oracle
ORCL
|
+$8.51M |
| 4 |
CrowdStrike
CRWD
|
+$6.24M |
| 5 |
GE Aerospace
GE
|
+$4.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$15.9M |
| 2 |
Microsoft
MSFT
|
+$14.3M |
| 3 |
DexCom
DXCM
|
+$13.4M |
| 4 |
Apple
AAPL
|
+$13.3M |
| 5 |
Microchip Technology
MCHP
|
+$13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.36% |
| 2 | Communication Services | 11.3% |
| 3 | Healthcare | 10.94% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Financials | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
International Flavors & Fragrances
IFF
$20.1B
| $1.39M | 0.04% |
16,466
| – | – |
|
77
Palo Alto Networks
PANW
$255B
| $1.2M | 0.04% |
6,600
| – | – |
|
78
Procter & Gamble
PG
$354B
| $1.13M | 0.04% |
6,720
| – | – |
|
79
Coca-Cola
KO
$385B
| $872K | 0.03% |
14,000
| – | – |
|
80
WEC Energy
WEC
$37.8B
| $747K | 0.02% |
7,941
| – | – |
|
|
OKLO
81
Oklo
OKLO
$6.73B
| $746K | 0.02% |
35,136
+5,469
| +18% | +$106K |
|
82
IBM
IBM
$204B
| $528K | 0.02% |
2,400
| – | – |
|
83
Salesforce
CRM
$148B
| $501K | 0.02% |
1,500
| – | – |
|
84
Qualcomm
QCOM
$174B
| $461K | 0.01% |
3,000
| – | – |
|
85
SPX Corp
SPXC
$10.5B
| $414K | 0.01% |
2,842
| – | – |
|
86
Dover
DOV
$27.7B
| $263K | 0.01% |
1,400
| – | – |
|
87
Danaher
DHR
$147B
| $230K | 0.01% |
1,000
| – | – |
|
88
Energy Recovery
ERII
$440M
| $221K | 0.01% |
15,000
| – | – |
|
89
Johnson & Johnson
JNJ
$657B
| $217K | 0.01% |
1,500
| – | – |
|
90
Bristol-Myers Squibb
BMY
$132B
| $204K | 0.01% |
+3,600
| New | +$201K |
|
91
BioMarin Pharmaceuticals
BMRN
$12.1B
| – | – |
-4,032
| Closed | -$283K |
|
|
92
DexCom
DXCM
$29.3B
| – | – |
-199,445
| Closed | -$13.4M |
|
93
Innovative Industrial Properties
IIPR
$1.79B
| – | – |
-2,000
| Closed | -$269K |
|
|
94
Microchip Technology
MCHP
$40.9B
| – | – |
-161,595
| Closed | -$13M |
|
|
SPR
95
DELISTED
Spirit AeroSystems
SPR
| – | – |
-159,439
| Closed | -$5.18M |
|
96
Constellation Brands
STZ
$22.9B
| – | – |
-800
| Closed | -$206K |
|
97
Teleflex
TFX
$5.97B
| – | – |
-5,600
| Closed | -$1.38M |
|
Similar funds
SC
EF
NAAA
GA
GHA
BCM
MA
GS
Aristotle Atlantic Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Aristotle Atlantic Partners held 97 positions worth $3.18B, down 1.1% from $3.22B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Aristotle Atlantic Partners withdrew a net $157M in Q4 2024, closing 7 positions and reducing 58 holdings. Its most notable exit was DexCom, an estimated $13.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 40% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, Aristotle Atlantic Partners opened a new position in GE Aerospace worth $4.41M.
- Aristotle Atlantic Partners's largest Q4 2024 buy was GE Aerospace: 26,427 shares worth $4.41M.
- Aristotle Atlantic Partners added most to Eli Lilly in Q4 2024, an estimated $12.9M increase.
- Aristotle Atlantic Partners's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $15.9M.
- Aristotle Atlantic Partners fully exited DexCom in Q4 2024, selling an estimated $13.4M.
- Aristotle Atlantic Partners's ten largest holdings make up 53% of its $3.18B portfolio in Q4 2024.
- Aristotle Atlantic Partners opened 2 new positions and closed 7 in Q4 2024.
- Aristotle Atlantic Partners's portfolio value fell 1.1% quarter-over-quarter to $3.18B.
Based on Aristotle Atlantic Partners's 13F filing for Q4 2024, filed 14 Feb 2025.